ScottCare Cardiovascular Solutions is a leading provider of state-of-the-art monitoring technologies, patient data management solutions, and labor services for ambulatory care settings within the healthcare industry. Their solutions play a crucial role in enabling accurate and cost-effective diagnosis, rehabilitation, and monitoring for cardiovascular patients, aiding in the overall management of cardiovascular disease. Led by the highly successful VersaCare system for cardiopulmonary rehab telemetry, ScottCare's portfolio includes a range of advanced technologies such as 3-in-1 remote cardiac monitoring, CIED patient data management, ambulatory blood pressure monitoring, arrhythmia event monitoring, and cardiac device monitoring labor services. A standout offering is the CardioView Dx, an integrated product suite that is recognized as the most comprehensive in the industry for cardiovascular diagnostic monitoring and CIED patient management. This suite incorporates OneView CRM, a device-neutral platform for managing cardiac implantable electronic device (CIED) data and reports from all CRM vendors. Operating since 1989 and headquartered in Cleveland, Ohio, ScottCare stands as a division of the Scott Fetzer Company, a wholly owned subsidiary of Berkshire Hathaway, Inc. Despite lacking recent investment details, the company's extensive experience, comprehensive product suite, and notable parent company give it a strong foundation within the healthcare industry.
There is no investment information
No recent news or press coverage available for ScottCare Cardiovascular Solutions.